| Year |
Citation |
Score |
| 2021 |
Wang L, Xu M, Hu H, Zhang L, Ye F, Jin J, Fang H, Chen J, Chen G, Broussy S, Vidal M, Lv Z, Liu WQ. A Cyclic Peptide Epitope of an Under-Explored VEGF-B Loop 1 Demonstrated Anti-Angiogenic and Anti-Tumor Activities. Frontiers in Pharmacology. 12: 734544. PMID 34658874 DOI: 10.3389/fphar.2021.734544 |
0.606 |
|
| 2020 |
Duflocq S, Zhou J, Huguenot F, Vidal M, Liu WQ. One-pot oxime ligation from peptides bearing thiazolidine and aminooxyacetyl groups. Rsc Advances. 10: 17681-17685. PMID 35515616 DOI: 10.1039/d0ra03235b |
0.492 |
|
| 2019 |
Brachet E, Dumond A, Liu WQ, Fabre M, Selkti M, Raynaud F, Hermine O, Benhida R, Belmont P, Garbay C, Lepelletier Y, Ronco C, Pagès G, Demange L. Synthesis, 3D-structure and stability analyses of NRPa-308, a new promising anti-cancer agent. Bioorganic & Medicinal Chemistry Letters. 126710. PMID 31699610 DOI: 10.1016/j.bmcl.2019.126710 |
0.557 |
|
| 2019 |
Wang L, Coric P, Broussy S, Di Stasi R, Zhou L, D'Andrea LD, Ji L, Vidal M, Bouaziz S, Liu WQ. Structural studies of the binding of an antagonistic cyclic peptide to the VEGFR1 domain 2. European Journal of Medicinal Chemistry. 169: 65-75. PMID 30856407 DOI: 10.1016/j.ejmech.2019.02.069 |
0.595 |
|
| 2018 |
Gomez-Zepeda D, Taghi M, Smirnova M, Sergent P, Liu WQ, Chhuon C, Vidal M, Picard M, Thioulouse E, Broutin I, Guerrera IC, Scherrmann JM, Parmentier Y, Decleves X, Menet MC. LC-MS/MS-based quantification of efflux transporter proteins at the BBB. Journal of Pharmaceutical and Biomedical Analysis. 164: 496-508. PMID 30453156 DOI: 10.1016/J.Jpba.2018.11.013 |
0.524 |
|
| 2017 |
Trapiella-Alfonso L, Broussy S, Liu WQ, Vidal M, Lecarpentier E, Tsatsaris V, Gagey-Eilstein N. Colorimetric immunoassays for the screening and specificity evaluation of molecules disturbing VEGFs/VEGFRs interactions. Analytical Biochemistry. PMID 29284120 DOI: 10.1016/j.ab.2017.12.029 |
0.543 |
|
| 2017 |
Wang L, Coric P, Zhu K, Liu WQ, Vidal M, Bouaziz S, Broussy S. Synthesis and characterization of water-soluble macrocyclic peptides stabilizing protein α-turn. Organic & Biomolecular Chemistry. PMID 29265149 DOI: 10.1039/c7ob02852k |
0.532 |
|
| 2017 |
Liu WQ, Lepelletier Y, Montes M, Borriello L, Jarray R, Grepin R, Leforban B, Loukaci A, Benhida R, Hermine O, Dufour S, Pages G, Garbay C, Raynaud F, Hadj-Slimane R, et al. NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model. Cancer Letters. PMID 29111348 DOI: 10.1016/J.Canlet.2017.10.039 |
0.767 |
|
| 2017 |
Wang L, Zhou L, Reille-Seroussi M, Gagey-Eilstein N, Broussy S, Zhang T, Ji L, Vidal M, Liu WQ. Identification of peptidic antagonists of vascular endothelial growth factor receptor-1 by scanning the binding epitopes of its ligands. Journal of Medicinal Chemistry. PMID 28686443 DOI: 10.1021/acs.jmedchem.7b00283 |
0.59 |
|
| 2017 |
Gomez-Zepeda D, Chaves C, Taghi M, Sergent P, Liu WQ, Chhuon C, Vidal M, Picard M, Thioulouse E, Broutin I, Guerrera IC, Scherrmann JM, Parmentier Y, Decleves X, Menet MC. Targeted unlabeled MRM analysis of cell markers for the study of sample heterogeneity in isolated rat brain cortical microvessels. Journal of Neurochemistry. PMID 28581635 DOI: 10.1111/Jnc.14095 |
0.497 |
|
| 2016 |
Rizzo-Padoin N, Chaussard M, Vignal N, Kotula E, Tsoupko-Sitnikov V, Vaz S, Hontonnou F, Liu WQ, Poyet JL, Vidal M, Merlet P, Hosten B, Sarda-Mantel L. [(18)F]MEL050 as a melanin-targeted PET tracer: Fully automated radiosynthesis and comparison to (18)F-FDG for the detection of pigmented melanoma in mice primary subcutaneous tumors and pulmonary metastases. Nuclear Medicine and Biology. 43: 773-780. PMID 27693672 DOI: 10.1016/j.nucmedbio.2016.08.010 |
0.452 |
|
| 2016 |
Rizzo-Padoin N, Chaussard M, Vignal N, Kotula E, Tsoupko-Sitnikov V, Vaz S, Hontonnou F, Liu WQ, Poyet JL, Vidal M, Merlet P, Hosten B, Sarda-Mantel L. [18F]MEL050 as a melanin-targeted PET tracer: Fully automated radiosynthesis and comparison to 18F-FDG for the detection of pigmented melanoma in mice primary subcutaneous tumors and pulmonary metastases Nuclear Medicine and Biology. 43: 773-780. DOI: 10.1016/j.nucmedbio.2016.08.010 |
0.434 |
|
| 2015 |
Haidar M, Whitworth J, Noé G, Liu WQ, Vidal M, Langsley G. TGF-β2 induces Grb2 to recruit PI3-K to TGF-RII that activates JNK/AP-1-signaling and augments invasiveness of Theileria-transformed macrophages. Scientific Reports. 5: 15688. PMID 26511382 DOI: 10.1038/srep15688 |
0.495 |
|
| 2015 |
Jarray R, Pavoni S, Borriello L, Allain B, Lopez N, Bianco S, Liu WQ, Biard D, Demange L, Hermine O, Garbay C, Raynaud F, Lepelletier Y. Disruption of phactr-1 pathway triggers pro-inflammatory and pro-atherogenic factors: New insights in atherosclerosis development. Biochimie. 118: 151-61. PMID 26362351 DOI: 10.1016/J.Biochi.2015.09.008 |
0.778 |
|
| 2015 |
Faivre L, Lecouflet L, Liu WQ, Khadher I, Lahaie C, Vidal M, Legouvello S, Beaumont JL, Bierling P, Rouard H, Birebent B. Quality control of extracorporeal photochemotherapy: Proliferation assay using CFSE validated according to ISO 15189:2007 standards. Cytometry. Part B, Clinical Cytometry. 88: 30-9. PMID 25227323 DOI: 10.1002/cyto.b.21188 |
0.464 |
|
| 2015 |
Wang L, Liu WQ, Saraux N, Vidal M, Broussy S. Solid phase synthesis of constrained 13-membered peptide macrocycles employing Fukuyama-Mitsunobu alkylations Tetrahedron Letters. 56: 2456-2459. DOI: 10.1016/j.tetlet.2015.03.091 |
0.495 |
|
| 2015 |
Jarray R, Pavoni S, Borriello L, Allain B, Lopez N, Bianco S, Liu WQ, Biard D, Demange L, Hermine O, Garbay C, Raynaud F, Lepelletier Y. Disruption of phactr-1 pathway triggers pro-inflammatory and pro-atherogenic factors: New insights in atherosclerosis development Biochimie. 118: 151-161. DOI: 10.1016/j.biochi.2015.09.008 |
0.741 |
|
| 2015 |
Liu W, Borriello L, Allain B, Pavoni S, Lopez N, Hermine O, Garbay C, Raynaud F, Lepelletier Y, Demange L. New Peptides Structurally Related to VEGF-A 165 Exon-7 and -8 Encoded Domains Antagonize Its Binding to NRP-1 and VEGF-R1 International Journal of Peptide Research and Therapeutics. 21: 117-124. DOI: 10.1007/S10989-014-9436-6 |
0.659 |
|
| 2014 |
Wang L, Gagey-Eilstein N, Broussy S, Reille-Seroussi M, Huguenot F, Vidal M, Liu WQ. Design and synthesis of C-terminal modified cyclic peptides as VEGFR1 antagonists. Molecules (Basel, Switzerland). 19: 15391-407. PMID 25264829 DOI: 10.3390/molecules191015391 |
0.574 |
|
| 2014 |
Liu WQ, Megale V, Borriello L, Leforban B, Montès M, Goldwaser E, Gresh N, Piquemal JP, Hadj-Slimane R, Hermine O, Garbay C, Raynaud F, Lepelletier Y, Demange L. Synthesis and structure-activity relationship of non-peptidic antagonists of neuropilin-1 receptor. Bioorganic & Medicinal Chemistry Letters. 24: 4254-9. PMID 25091928 DOI: 10.1016/J.Bmcl.2014.07.028 |
0.621 |
|
| 2014 |
Borriello L, Montès M, Lepelletier Y, Leforban B, Liu WQ, Demange L, Delhomme B, Pavoni S, Jarray R, Boucher JL, Dufour S, Hermine O, Garbay C, Hadj-Slimane R, Raynaud F. Structure-based discovery of a small non-peptidic Neuropilins antagonist exerting in vitro and in vivo anti-tumor activity on breast cancer model. Cancer Letters. 349: 120-7. PMID 24752068 DOI: 10.1016/J.Canlet.2014.04.004 |
0.783 |
|
| 2012 |
Allain B, Jarray R, Borriello L, Leforban B, Dufour S, Liu WQ, Pamonsinlapatham P, Bianco S, Larghero J, Hadj-Slimane R, Garbay C, Raynaud F, Lepelletier Y. Neuropilin-1 regulates a new VEGF-induced gene, Phactr-1, which controls tubulogenesis and modulates lamellipodial dynamics in human endothelial cells. Cellular Signalling. 24: 214-23. PMID 21939755 DOI: 10.1016/J.Cellsig.2011.09.003 |
0.77 |
|
| 2009 |
Dourlat J, Liu WQ, Sancier F, Edmonds T, Pamonsinlapatham P, Cruzalegui F, Garbay C. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity. Biochimie. 91: 996-1002. PMID 19470402 DOI: 10.1016/J.Biochi.2009.05.006 |
0.672 |
|
| 2009 |
Verma NK, Dourlat J, Davies AM, Long A, Liu WQ, Garbay C, Kelleher D, Volkov Y. STAT3-stathmin interactions control microtubule dynamics in migrating T-cells. The Journal of Biological Chemistry. 284: 12349-62. PMID 19251695 DOI: 10.1074/Jbc.M807761200 |
0.595 |
|
| 2008 |
Ye YB, Lin JY, Chen Q, Liu F, Chen HJ, Li JY, Liu WQ, Garbay C, Vidal M. The cytotoxicity of a Grb2-SH3 inhibitor in Bcr-Abl positive K562 cells. Biochemical Pharmacology. 75: 2080-91. PMID 18455151 DOI: 10.1016/j.bcp.2007.12.021 |
0.687 |
|
| 2008 |
Luzy JP, Chen H, Gril B, Liu WQ, Vidal M, Perdereau D, Burnol AF, Garbay C. Development of binding assays for the SH2 domain of Grb7 and Grb2 using fluorescence polarization. Journal of Biomolecular Screening. 13: 112-9. PMID 18216394 DOI: 10.1177/1087057107312124 |
0.692 |
|
| 2007 |
Dourlat J, Valentin B, Liu WQ, Garbay C. New syntheses of tetrazolylmethylphenylalanine and O-malonyltyrosine as pTyr mimetics for the design of STAT3 dimerization inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 3943-6. PMID 17509878 DOI: 10.1016/J.Bmcl.2007.04.107 |
0.589 |
|
| 2007 |
Gril B, Vidal M, Assayag F, Poupon MF, Liu WQ, Garbay C. Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel. International Journal of Cancer. 121: 407-15. PMID 17372910 DOI: 10.1002/Ijc.22674 |
0.705 |
|
| 2007 |
Dourlat J, Liu WQ, Gresh N, Garbay C. Novel 1,4-benzodiazepine derivatives with antiproliferative properties on tumor cell lines. Bioorganic & Medicinal Chemistry Letters. 17: 2527-30. PMID 17317183 DOI: 10.1016/J.Bmcl.2007.02.016 |
0.583 |
|
| 2007 |
Noureddine H, Schmitt C, Liu W, Garbay C, Massoulié J, Bon S. Assembly of acetylcholinesterase tetramers by peptidic motifs from the proline-rich membrane anchor, PRiMA: competition between degradation and secretion pathways of heteromeric complexes. The Journal of Biological Chemistry. 282: 3487-97. PMID 17158452 DOI: 10.1074/Jbc.M607221200 |
0.606 |
|
| 2007 |
Leroux V, Gresh N, Liu WQ, Garbay C, Maigret B. Role of water molecules for binding inhibitors in the SH2 domain of Grb2: A molecular dynamics study Journal of Molecular Structure: Theochem. 806: 51-66. DOI: 10.1016/J.Theochem.2006.11.010 |
0.629 |
|
| 2005 |
Gobert Gosse S, Bourgin C, Liu WQ, Garbay C, Mouchiroud G. M-CSF stimulated differentiation requires persistent MEK activity and MAPK phosphorylation independent of Grb2-Sos association and phosphatidylinositol 3-kinase activity. Cellular Signalling. 17: 1352-62. PMID 16125055 DOI: 10.1016/J.Cellsig.2005.02.002 |
0.544 |
|
| 2005 |
Vidal M, Liu W, Gril B, Lenoir C, Garbay C. Inhibitors of tyrosine kinase proteins induced Ras signaling pathway as potential anti-tumor agents Comptes Rendus Chimie. 8: 815-821. DOI: 10.1016/J.CRCI.2005.02.014 |
0.678 |
|
| 2004 |
Dvir H, Harel M, Bon S, Liu WQ, Vidal M, Garbay C, Sussman JL, Massoulié J, Silman I. The synaptic acetylcholinesterase tetramer assembles around a polyproline II helix. The Embo Journal. 23: 4394-405. PMID 15526038 DOI: 10.1038/Sj.Emboj.7600425 |
0.665 |
|
| 2004 |
Vidal M, Liu WQ, Gril B, Assayag F, Poupon MF, Garbay C. [Design of new anti-tumor agents interrupting deregulated signaling pathways induced by tyrosine kinase proteins. Inhibition of protein-protein interaction involving Grb2]. Journal De La Societe De Biologie. 198: 133-7. PMID 15368963 |
0.71 |
|
| 2004 |
Liu WQ, Vidal M, Olszowy C, Million E, Lenoir C, Dhôtel H, Garbay C. Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs. Journal of Medicinal Chemistry. 47: 1223-33. PMID 14971902 DOI: 10.1021/Jm031005K |
0.709 |
|
| 2002 |
Saci A, Liu WQ, Vidal M, Garbay C, Rendu F, Bachelot-Loza C. Differential effect of the inhibition of Grb2-SH3 interactions in platelet activation induced by thrombin and by Fc receptor engagement. The Biochemical Journal. 363: 717-25. PMID 11964172 DOI: 10.1042/0264-6021:3630717 |
0.704 |
|
| 2002 |
Nioche P, Liu WQ, Broutin I, Charbonnier F, Latreille MT, Vidal M, Roques B, Garbay C, Ducruix A. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor. Journal of Molecular Biology. 315: 1167-77. PMID 11827484 DOI: 10.1006/Jmbi.2001.5299 |
0.735 |
|
| 2002 |
Liu WQ, Olszowy C, Bischoff L, Garbay C. Enantioselective synthesis of (2S)-2-(4-phosphonophenylmethyl)-3-aminopropanoic acid suitably protected for peptide synthesis Tetrahedron Letters. 43: 1417-1419. DOI: 10.1016/S0040-4039(02)00004-7 |
0.59 |
|
| 2000 |
Garbay C, Liu W, Vidal M, Roques BP. Inhibitors of RAS signal transduction as antitumor agents Biochemical Pharmacology. 60: 1165-1169. PMID 11007954 DOI: 10.1016/S0006-2952(00)00428-7 |
0.737 |
|
| 2000 |
Liu W, Vidal M, Mathé C, Périgaud C, Garbay C. Inhibition of the ras-dependent mitogenic pathway by phosphopeptide prodrugs with antiproliferative properties. Bioorganic & Medicinal Chemistry Letters. 10: 669-672. PMID 10762050 DOI: 10.1016/S0960-894X(00)00077-9 |
0.7 |
|
| 1999 |
Liu WQ, Vidal M, Gresh N, Roques BP, Garbay C. Small peptides containing phosphotyrosine and adjacent alphaMe-phosphotyrosine or its mimetics as highly potent inhibitors of Grb2 SH2 domain. Journal of Medicinal Chemistry. 42: 3737-41. PMID 10479306 DOI: 10.1021/Jm9911074 |
0.696 |
|
| 1999 |
Cussac D, Vidal M, Leprince C, Liu W, Cornille F, Tiraboschi G, Roques BP, Garbay C. A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity The Faseb Journal. 13: 31-39. PMID 9872927 DOI: 10.1096/Fasebj.13.1.31 |
0.733 |
|
| 1997 |
Liu W, Roques BP, Garbay C. Synthesis of L-2,3,5,6-tetrafluoro-4-(phosphonomethyl) phenylalanine, a novel non-hydrolyzable phosphotyrosine mimetic and L-4-(phosphonodifluoromethyl)phenylalanine Tetrahedron Letters. 38: 1389-1392. DOI: 10.1016/S0040-4039(97)00027-0 |
0.547 |
|
| 1996 |
Liu W, Carreaux F, Meudal H, Roques BP, Garbay-Jaureguiberry C. Synthesis of Constrained 4-(Phosphonomethyl)Phenylalanine Derivatives As Hydrolytically Stable Analogs of O- Phosphotyrosine. Tetrahedron. 52: 4411-4422. DOI: 10.1016/0040-4020(96)00085-3 |
0.332 |
|
| 1996 |
baczko K, Liu W, Roques BP, Garbay-Jaureguiberry C. New synthesis of D,L-fmoc protected 4- phosphonomethylphenylalanine derivatives and their enzymatic resolution Tetrahedron. 52: 2021-2030. DOI: 10.1016/0040-4020(95)01003-3 |
0.307 |
|
| Show low-probability matches. |